LUKE DAGOSTINO: Open Payments
NPI 1689121725 · FISHKILL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,768 in 114 payments from 16 companies in 2025. Trend: 2023 $1,159 · 2024 $1,897 · 2025 $1,768
Food & beverage: $1,752Education: $16
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $461 |
| Incyte Corporation | 20 | $176 |
| Regeneron Healthcare Solutions, Inc. | 6 | $162 |
| LEO Pharma Inc. | 7 | $142 |
| Novartis Pharmaceuticals Corporation | 6 | $139 |
| Galderma Laboratories, L.P. | 6 | $123 |
| E.R. Squibb & Sons, L.L.C. | 4 | $108 |
| Lilly USA, LLC | 6 | $105 |
| Organon LLC | 6 | $95 |
| UCB, Inc. | 2 | $74 |
Products named: SKYRIZI, OPZELURA, DUPIXENT, ADBRY, COSENTYX, Sotyktu, RINVOQ, NEMLUVIO.
Industry payments across NY — which companies pay providers there.
